Breast Cancer Clinical Trial

Clinical Trial Finder Breast Cancer Trials

Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.

See Locations Near You

Summary

To determine the safety and efficacy of LY353381 when compared to tamoxifen in women with advanced or metastatic breast cancer.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria

Locally advanced or metastatic breast cancer
Bi-dimensionally measurable disease

Exclusion Criteria

1. Prior hormonal therapy

Study is for people with:

Breast Cancer

Phase:

Phase 3

Study ID:

NCT00034125

Recruitment Status:

Completed

Sponsor:

Eli Lilly and Company

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You


Miami Florida, , United States

Shreveport Louisiana, , United States

Boston Massachusetts, , United States

Nashville Tennessee, , United States

Capital Federal Buenos Aires, , Argentina

Ciudad De Buenos Aires , , Argentina

Las Condes Santiago, , Chile

Providencia Santiago, , Chile

Ahmedabab Gujarat, , India

Mexico City Benito Juarez, , Mexico

Colima , , Mexico

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Phase:

Phase 3

Study ID:

NCT00034125

Recruitment Status:

Completed

Sponsor:


Eli Lilly and Company

How clear is this clinincal trial information?

Clinical Trial Resources

SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials for Breast Cancer
Have You Been Diagnosed With Late-Stage Breast Cancer? Know That You Have Treatment Options.
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider